Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
about
Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer.Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editingVolasertib suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.Caragaphenol a induces reactive oxygen species related apoptosis in human gastric cancer cells.YM155 enhances docetaxel efficacy in ovarian cancer.
P2860
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
@en
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
@nl
type
label
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
@en
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
@nl
prefLabel
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
@en
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
@nl
P2093
P2860
P1476
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
@en
P2093
Di-Wei Zheng
Jia-Rong Huang
Jian-Ge Qiu
Ke-Jun Cheng
Meng-Ning Wei
Qi-Wei Jiang
Wen-Ji Zhang
Wu-Ming Qin
P2860
P304
P407
P577
2016-07-15T00:00:00Z